Can a nerve drug restore function after prostate cancer surgery?

NCT ID NCT03701581

Recruiting now Symptom relief Sponsor: John Elfar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether 4-aminopyridine (4-AP) can help men recover faster from nerve damage caused during prostate cancer surgery. About 70 men aged 45-75 with early-stage prostate cancer will take the drug or a placebo after their operation. The goal is to see if it improves bladder control and erectile function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NERVE INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction prostate cancer traumatic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NERVE INJURY PROSTATE CANCER

Contacts and locations

Locations

University of Arizona
RECRUITING

Tucson, Arizona, 85724, United States
University of Rochester
TERMINATED

Rochester, New York, 14602, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.